ABOUT THIS EPISODE

How often do you come across someone who graduated from university and was given the job of managing the money of UBS (one of the biggest investment banks in the world), then went on to become Vice President at Morgan Stanely, Managing Director of Derivatives at The Galleon Group and then president of the $400 million hedge fund, Cramer Berkowitz? Oh, and if that wasn't enough, our guest then started Minyanville Media, an Emmy Award winning financial media company and now is founding partner and Chief Investment Officer of CB1 Capital - an investment manager that specialises in the supply chain of cannabinoid-based wellness solutions and products. He's the King of Pot on Wall St.

It's not often you meet someone with a resume so impressive, so it was with great excitement that we sat down to speak with Todd Harrison. Todd has appeared on FOX, CNBC, CNN and he is published in the Wall Street Journal, Business Week and Fortune.

In this episode you will learn:

    Why Todd thinks Australia is the service station to the Southern Hemisphere when it comes to this industry What will happen when big pharmaceuticals become buyers Which market Todd thinks is really about to take root What place biotech has in the marijuana industry Some of the stocks on Todd's watchlist That large institutions can't buy pot stocks

Stocks and resources discussed:

English
United States

TRANSCRIPT

Transcribe this episode
We transcribe podcasts (Example). Transcribing all podcasts in the world takes time... Please help us prioritize what episodes to transcribe.
Disclaimer: The podcast and artwork embedded on this page are from Equity Mates Investing Podcast, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.

EDIT

Thank you for helping to keep the podcast database up to date.